Sunday, September 25, 2011

PhysOrg Newsletter Sunday, Sep 25

Dear Reader ,

Here is your customized PHYSorg.com Newsletter for September 25, 2011:

Spotlight Stories Headlines

- Study puts a new spin on ibuprofen's actions
- Toyota three-wheeler does 80.3 mph on compressed air
- A heart of gold: Better tissue repair after heart attack
- Jumping gene enabled key step in corn domestication
- Invasion of genomic parasites triggered modern mammalian pregnancy
- Deep brain stimulation studies show how brain buys time for tough choices
- Rogue receptor opens door for rare kidney disease
- Mice stem cells guided into myelinating cells by the trillions
- Satellite landed, exact site not yet known: NASA
- Piezoelectric film used for new remote that twists and bends
- New discoveries in genetics of lung health

Space & Earth news

Hundreds in Seattle rally against fossil fuel use
(AP) -- A few hundred people in Seattle have joined citizens around the globe in rallying against fossil fuel use and in support of alternative means of transportation.

The American 'allergy' to global warming: Why?
(AP) -- Tucked between treatises on algae and prehistoric turquoise beads, the study on page 460 of a long-ago issue of the U.S. journal Science drew little attention.

NASA satellite plunges into Pacific off California
A bus-sized US satellite that hurtled unpredictably toward Earth crossed over Africa and the northern Atlantic before likely plunging into the Pacific Ocean off California, NASA said on Saturday.

Hoping for mining boom, Canada opens last frontier
Dropping beneath low-lying clouds, a float plane circles a rocky landscape on the edge of the Arctic Circle grooved by the last ice age eight millennia ago and since then bathed by hundreds of rivers and lakes.

Satellite landed, exact site not yet known: NASA
A decommissioned NASA satellite, the biggest piece of US space junk to fall in 30 years, has crash-landed but the precise location is not yet known, the US space agency said early Saturday.

Technology news

Atop Meg Whitman's worries: H-P's size
(AP) -- Meg Whitman's primary job as Hewlett-Packard Co.'s new CEO will be to restore a sense of direction at a company that has lost its way after a decade of leadership lapses and disjointed deal-making.

NinjaVideo founder pleads to copyright charges
A founder of the NinjaVideo website that offered downloads of current movies and television shows pleaded guilty Friday to criminal copyright violations, officials said.

Apple opens Hong Kong store in China push
Apple threw open the doors to its first store in Hong Kong Saturday, its latest push to tap the booming China market, as protesters accused the technology giant of supporting sweatshop labour.

Top Groupon exec jumps back to Google
Groupon revealed that the startup's chief operating officer was leaving after just five months for a job at her former employer -- Google.

'Multiple parties' interested in Yahoo!: memo
Yahoo! is fielding inquiries from "multiple parties" who have expressed an interest in the struggling Internet company, officials said Friday in a memo sent to employees and obtained by AFP.

LA hardware issue led to outage for AT&T customers (Update)
(AP) -- AT&T wireless customers in Los Angeles County are texting and making calls again after technicians fixed a widespread outage.

BBC News, Al Jazeera take online journalism honors
BBC News, Al Jazeera and The Los Angeles Times scooped up the top prizes as the Online News Association (ONA) handed out its annual awards on Saturday.

Samsung says 10 million Galaxy S II handsets sold
South Korea's Samsung Electronics, the world's second-largest mobile phone maker after Nokia, said Sunday it had sold 10 million Galaxy S II smartphones worldwide since the device debuted in April.

Senator says OnStar invades privacy
The OnStar automobile communication service used by 6 million Americans maintains its two-way connection with a customer even after the service is discontinued, while reserving the right to sell data from that connection.

Piezoelectric film used for new remote that twists and bends
(PhysOrg.com) -- Murata Manufacturing Co. is using high-transparency organic piezoelectric film for its two new devices, a remote control that works by bending and twisting, and a touch-pressure pad that connects to PCs. Murata will ship samples of both devices next year.

Toyota three-wheeler does 80.3 mph on compressed air
(PhysOrg.com) -- Toyota Industries intends to apply for a Guiness World record for the fastest car driven by a compressed-air engine, after its Ku:Rin, as the vehicle is called, reached 129.2km/h (80.3 mph)on a test run earlier this month. This is a three-wheel, one-seater vehicle that broke the speed record for compressed air-powered vehicles at the Japan Automobile Research Institute test facility.

Medicine & Health news

Two new cost-effective ways to predict prostate cancer
Two new risk indicators for prostate cancer will be unveiled at the 2011 European Multidisciplinary Cancer Congress today (Saturday).

Living in damp river valleys leads to lung problems
Amsterdam, The Netherlands: A new study has shown that living in a river valley at low altitude can increase the risk of developing lung problems.

First Phase III trial of an alpha-pharmaceutical
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported today (Saturday) at the 2011 European Multidisciplinary Cancer Congress.

Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.

Japan finds radiation in rice, more tests planned
(AP) -- Japan is ordering more tests on rice growing near a crippled nuclear plant after finding elevated levels of radiation, government officials said Saturday.

Treatment of rectal cancer varies enormously between different European countries
Stockholm, Sweden: First results from an international comparison of the care of patients with rectal cancer have shown there are substantial differences in the use of chemotherapy and radiotherapy between European countries.

Goats could increase the risk of a rare lung cancer
Exposure to goats could increase the risk of a certain type of lung cancer, according to French researchers.

Study sheds light on the impact of COPD on working aged populations
New research has revealed the devastating personal and financial impact that chronic obstructive pulmonary disease (COPD) can have on the working population.

New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
Stockholm, Sweden: Inhibiting a protein involved in bone metabolism can delay the onset of the bone metastases which are common in men with a particular form of prostate cancer, a researcher will tell the 2011 European Multidisciplinary Cancer Congress today (Sunday).

Alcohol can reduce asthma risk
Drinking alcohol in moderate quantities can reduce the risk of asthma, according to Danish researchers.

Phase II study shows new cancer drug combination significantly delays breast cancer progression
The first randomised trial to investigate the use of trastuzumab emtansine (T-DM1) – an antibody-guided drug – for the initial treatment of HER2- (human epidermal growth factor receptor-2) positive metastatic breast cancer has shown that it makes a significant difference to the time women live without their disease worsening.

Radiotherapy between or during chemotherapy cycles reduces risk of breast cancer recurrence
Stockholm, Sweden: A major UK trial has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall. The treatment, known as synchronous chemoradiation, has minimal adverse side-effects and no detrimental effect on the patients' quality of life.

New diagnostic imaging for lung cancer could prevent unnecessary surgery
A new type of diagnostic imaging - which can better differentiate benign lung lesions from those which are cancerous - could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease.

Breast cancer tumor make-up changes through the course of disease
New research has found that breast cancer tumours change their hormonal status throughout the course of disease, whereas the decision about the most effective treatment for the patient is usually only based on one biopsy of the primary tumour. For some patients, biopsy verifications of any relapse will be very important because it may completely change their clinical management, a Swedish researcher will tell the 2011 European Multidisciplinary Cancer Congress today (Monday 26 September). Dr. Linda Lindström, from the Karolinska Institutet Department of Oncology-Pathology, Solna, Stockholm, will say that her group's research is the first sizeable study to look at changes in tumours in multiple relapses in breast cancer patients.

Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years
Stockholm, Sweden: Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.

Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
Stockholm, Sweden: Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, according to results from a phase III clinical trial presented today.

Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress today. Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care.

Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented today at the 2011 European Multidisciplinary Cancer Congress.

Discovery helps explain why chemo causes drop in platelet numbers
Scientists at the Walter and Eliza Hall Institute have identified a way that chemotherapy causes platelet numbers to drop, answering in the process a decade-old question about the formation of platelets, tiny cells that allow blood to clot.

'Belly fat' linked to development of asthma
Belly fat, known clinically as central obesity, has been linked to the development of asthma in a new study.

Foam injections for varicose veins better for patients and cheaper, study finds
Foam injections to treat varicose veins cause less pain for patients and could save NHS money compared with a popular alternative treatment, according to researchers at Imperial College London. The study found that foam therapy was over four times more cost-effective than laser treatment and allowed patients to resume normal activity sooner. The findings were presented today at the annual meeting of the European Vascular Society in Athens.

Couples counseling improves sexual intimacy after prostate treatment
Prostate cancer survivors and their partners experience improved sexual satisfaction and function after couples counseling, according to research at The University of Texas MD Anderson Cancer Center. The article, published in the September issue of Cancer, a journal of the American Cancer Society, revealed both Internet-based sexual counseling and traditional sex therapy are equally effective in improving sexual outcomes. Couples on a waiting list for counseling did not improve.

City cyclists are at increased risk from lung injury from inhaled soot
People who cycle through London and other major cities have higher levels of black carbon in their airway cells, experts from the UK have shown.

Stopping smoking boosts everyday memory
Giving up smoking isn’t just good for your health, it’s also good for your memory, according to research from Northumbria University.

Mice stem cells guided into myelinating cells by the trillions
Scientists at Case Western Reserve University School of Medicine found a way to rapidly produce pure populations of cells that grow into the protective myelin coating on nerves in mice. Their process opens a door to research and potential treatments for multiple sclerosis, cerebral palsy and other demyelinating diseases afflicting millions of people worldwide.

Rogue receptor opens door for rare kidney disease
Effects of a particularly devastating human kidney disease may be blunted by making a certain cellular protein receptor much less receptive, according to new research by scientists from North Carolina State University and a number of French universities and hospitals.

New discoveries in genetics of lung health
Scientists have for the first time discovered sixteen new sections of the genetic code that relate to lung health -- opening up the possibility for better prevention as well as treatment for lung diseases.

Study puts a new spin on ibuprofen's actions
Ibuprofen, naproxen, and related non-steroidal anti-inflammatory drugs (NSAIDs) – the subjects of years of study – still have some secrets to reveal about how they work.

Deep brain stimulation studies show how brain buys time for tough choices
Take your time. Hold your horses. Sleep on it. When people must decide between arguably equal choices, they need time to deliberate. In the case of people undergoing deep brain stimulation (DBS) for Parkinson's disease, that process sometimes doesn't kick in, leading to impulsive behavior. New research into why that happens has led scientists to a detailed explanation of how the brain devotes time to reflect on tough choices.

Biology news

GM food solutions at risk from lobbyists, research suggests
Powerful lobby groups opposed to genetically modified (GM) food are threatening public acceptance of the technology in Europe, research suggests.

Jumping gene enabled key step in corn domestication
Corn split off from its closest relative teosinte, a wild Mexican grass, about 10,000 years ago thanks to the breeding efforts of early Mexican farmers. Today it's hard to tell that the two plants were ever close kin: Corn plants stand tall, on a single sturdy stalk, and produce a handful of large, kernel-filled ears. By contrast, teosinte is branchy and bushy, with scores of thumb-sized "ears," each containing only a dozen or so hard-shelled kernels.

Invasion of genomic parasites triggered modern mammalian pregnancy
Genetic parasites invaded the mammalian genome more than 100 million years ago and dramatically changed the way mammals reproduce -- transforming the uterus in the ancestors of humans and other mammals from the production of eggs to a nurturing home for developing young, a new Yale University study has found.


This email is a free service of PhysOrg.com
You received this email because you subscribed to our list.
If you no longer want to receive this email use the link below to unsubscribe.
http://www.physorg.com/profile/nwletter/
You are subscribed as jmabs1@gmail.com

No comments: